ELTP · Elite Pharmaceuticals Inc /Nv/ · Documents
$0.22
0.00 (-2.01%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 29, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$242.36M
Shares
1.08B
Volume · Oct 5
1.66M
Avg daily vol (3M)
765.29K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-13 | — | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K/A | 2026-08-11 | 2026-08-10 | |
| 8-K | 2026-08-10 | — | |
| 8-K | 2026-08-04 | — | |
| 10-K | 2026-06-29 | 2026-03-31 | |
| 8-K | 2026-06-29 | — | |
| 8-K | 2026-06-23 | — | |
| 8-K | 2026-06-15 | — | |
| 8-K | 2026-06-01 | 2026-05-29 | |
| 8-K | 2026-04-02 | — | |
| Investor Event Transcript | 2026-03-31 | 2025-06-30 | |
| 10-Q | 2026-02-17 | 2025-12-31 | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2026-02-11 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-14 | — | |
| 8-K | 2025-11-12 | — | |
| 8-K/A | 2025-11-12 | 2025-11-10 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-08 | — | |
| 10-K | 2025-06-30 | 2025-03-31 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-16 | — | |
| 8-K | 2025-04-30 | — | |
| Investor Event Transcript | 2025-03-31 | — | |
| 8-K | 2025-03-03 | 2025-02-28 | |
| 8-K | 2025-02-13 | — | |
| 10-Q | 2025-02-13 | 2024-12-31 | |
| 8-K | 2024-12-26 | — | |
| 8-K | 2024-12-02 | — | |
| 8-K | 2024-11-18 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-10-10 | — | |
| 8-K | 2024-10-07 | — | |
| 8-K | 2024-08-27 | — | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 10-K | 2024-07-01 | 2024-03-31 | |
| 8-K | 2024-07-01 | — | |
| 8-K | 2024-06-21 | 2024-06-17 | |
| 8-K | 2024-06-05 | 2024-06-01 | |
| 8-K | 2024-05-20 | — | |
| 10-Q | 2024-02-14 | 2023-12-31 | |
| 8-K | 2024-02-14 | — | |
| 8-K | 2023-12-26 | — |
Showing 1–50 of 114 filings